|
Originally published In Press as doi:10.1074/jbc.M200387200 on March 28, 2002
J. Biol. Chem., Vol. 277, Issue 23, 20468-20476, June 7, 2002
Characterization of Oligopeptides That Cross-react with
Carbohydrate-specific Antibodies by Real Time Kinetics, In-solution
Competition Enzyme-linked Immunosorbent Assay, and Immunological
Analyses*
Paul J.
Brett ,
Harmale
Tiwana ,
Ian M.
Feavers§, and
Bambos
M.
Charalambous ¶
From the Department of Medical Microbiology, Royal
Free and University College Medical School, Royal Free Campus,
University College London, Rowland Hill Street, London NW3 2PF and
§ Division of Bacteriology, National Institute for
Biological Standards and Control, Blanche Lane, South Mimms,
Hertfordshire EN6 3QG, United Kingdom
Phage displaying random cyclic 7-mer, and linear
7-mer and 12-mer peptides at the N terminus of the coat protein, pIII,
were panned with the murine monoclonal antibody, 9-2-L379 specific for
meningococcal lipo-oligosaccharide. Five cyclic peptides with two
sequence motifs, six linear 7-mers, and five linear 12-mers with
different sequence motifs were identified. Only phage displaying cyclic
peptides were specifically captured by and were antigenic for 9-2-L379.
Monoclonal antibody 9-2-L379 exhibited "apparent" binding
affinities to the cyclic peptides between 11 and 184 nM, comparable with lipo-oligosaccharide. All cyclic
peptides competed with the binding of 9-2-L379 to lipo-oligosaccharide
with EC50 values in the range 10-105 µM,
which correlated with their apparent binding affinities.
Structural modifications of the cyclic peptides eliminated their
ability to bind and compete with monoclonal antibody 9-2-L379. Mice
(C3H/HeN) immunized with the cyclic peptide with optimal apparent
binding affinity and EC50 of competition elicited cross-reactive antibodies to meningococcal lipo-oligosaccharide with
end point dilution serum antibody titers of 3200. Cyclic peptides were
converted to T-cell-dependent immunogens without disrupting
these properties by C-terminal biotinylation and complexing with
NeutrAvidin®. The data indicate that constrained peptides can
cross-react with a carbohydrate-specific antibody with greater specificity than linear peptides, and critical to this specificity is
their structural conformation.
*
This work was supported in part by the Meningitis Research
Foundation (to P. J. B. and H. T.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed. Tel.:
44-20-7472-6402; Fax: 44-20-7794-0433; E-mail:
b.charalambous@rfc.ucl.ac.uk.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. N. Dharmasena, S. J. Krebs, and R. K. Taylor
Characterization of a novel protective monoclonal antibody that recognizes an epitope common to Vibrio cholerae Ogawa and Inaba serotypes
Microbiology,
July 1, 2009;
155(7):
2353 - 2364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Menendez, D. A. Calarese, R. L. Stanfield, K. C. Chow, C. N. Scanlan, R. Kunert, H. Katinger, D. R. Burton, I. A. Wilson, and J. K. Scott
A peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120
FASEB J,
May 1, 2008;
22(5):
1380 - 1392.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|